Suven Life Sciences reports consolidated net loss of Rs 51.52 crore in the June 2025 quarter
(13 Aug 2025)

Back
Net Loss of Suven Life Sciences reported to Rs 51.52 crore in the quarter ended June 2025 as against net loss of Rs 28.04 crore during the previous quarter ended June 2024. Sales rose 85.15% to Rs 1.87 crore in the quarter ended June 2025 as against Rs 1.01 crore during the previous quarter ended June 2024.

ParticularsQuarter Ended
Jun. 2025Jun. 2024% Var.
Sales1.871.01 85
OPM %-2713.90-3023.76 -
PBDT-50.15-26.55 -89
PBT-51.52-28.04 -84
NP-51.52-28.04 -84

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew